Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

As one of the most published scientists on the effects of psychedelics, Johnson explains the medicine is potentially working on two levels.

“There’s depression and addiction treatment … where a number of published studies have shown psychedelic treatment to be extremely promising in comparison with SSRIs like prozac. The other category, though, is neurological.”

Johnson explains studies like those conducted by the University of California, have found psychedelic treatments to induce neuroplastic effects in brains of rats.

“Their brains seem to be rewiring and healing,” he says of the exploratory work that has not yet been tested on humans.

While Johnson is careful not to encourage any use of psychedelics outside of research environments, or to suggest their ability to rebuild brains is anything other than theoretical, he remains excited by the potential the future offers.


https://www.theguardian.com/sport/2021/jun/14/psychedelics-boxing-brain-trauma-mike-tyson-therapeutic-use